Pfizer announced it is ending its development of its experimental oral GLP-1 drug to treat obesity, the company said on Monday, after a patient in a trial suffered a liver injury potentially caused by the experimental drug known as danuglipron.
Read More Pfizer Pulls Plug On Weight Loss Pill Amid Liver Damage FearsTag: Obesity
RFK Jr. Sworn In As Secretary Of Health And Human Services
Robert F. Kennedy Jr. has officially been sworn in as the new Human and Health Services Secretary.
Read More RFK Jr. Sworn In As Secretary Of Health And Human ServicesResearchers Propose New Method To Measure, Diagnose Obesity
After decades of physicians relying primarily on body-mass index to diagnose obesity, researchers are advocating for a more nuanced measurement.
Read More Researchers Propose New Method To Measure, Diagnose ObesityU.S. Surgeon General’s New Advisory Links Alcohol To Increased Cancer Risk
The U.S. Surgeon General has released a new advisory warning of alcohol-related cancer risk.
Read More U.S. Surgeon General’s New Advisory Links Alcohol To Increased Cancer RiskU.S. Obesity Rate Declines In 2023 Amid Rising Use Of Weight Loss Products
The U.S. obesity rate declined for the first time in a decade last year, coinciding with the rise of weight loss drugs such as Ozempic, a new study has found.
Read More U.S. Obesity Rate Declines In 2023 Amid Rising Use Of Weight Loss ProductsThe Significance Of The Trump-RFK Healthcare Revolution
By Rick Amato
November 14, 2024
(Views expressed by guest commentators may not reflect the views of OAN or its affiliates.)
Read More The Significance Of The Trump-RFK Healthcare Revolution